Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

22 projects found matching your search criteria :

  1. Study on vaccine antigen deficient Bordetella pertussis strains as a possible result of pertussis vaccine-driven pressio...

    Call: PRELUDIUM 5 , Panel: NZ7

    Principal investigator: Maciej Marcin Polak

    Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy

  2. The effect of imipramine and risperidone on regulation of the chronic mild stress-induced anhedonia and memory impairmen...

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  3. Legal instruments of sustainability of public finances - implications to Poland from foreign countries experiences

    Call: PRELUDIUM 3 , Panel: HS5

    Principal investigator: dr Urszula Kinga Zawadzka-Pąk

    Uniwersytet w Białymstoku, Wydział Prawa

  4. Problems of Forest Nature Deficit in Polish and Austrian society-an attempt to create a psychometric questionnaire defin...

    Call: OPUS 27 , Panel: NZ9

    Principal investigator: dr Natalia Korcz

    Instytut Badawczy Leśnictwa

  5. Assessment of the ketogenic diet and physical activity in obese ovariectomized female mice.

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Mateusz Mariusz Grabowski

    Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach

  6. Optogenetic and chemogenetic identification of brain circuits and cellular mechanisms underlying antidepressants resista...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  7. The role of GPR39 receptor in the mechanism of antidepressant action

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Katarzyna Młyniec

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  8. Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease

    Call: OPUS 22 (LAP) , Panel: NZ7

    Principal investigator: prof. Kinga Aleksandra Sałat

    Uniwersytet Jagielloński, Collegium Medicum

  9. Bioabsorbable hydroxyapatite/polymer nanocomposite granules with enhanced osteoconductivity and anti-inflammatory proper...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: dr Vladyslav Vivcharenko

    Uniwersytet Medyczny w Lublinie

  10. Impact of voluntary physical activity and exercise mimetics on the neuroinflammation-related changes induced by an estro...

    Call: PRELUDIUM 20 , Panel: NZ7

    Principal investigator: dr Konstancja Imogena Grabowska

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

  11. Investigation of molecular mechanisms of rapid antidepressant action of NLX-101, a biased agonist of the 5-HT1A receptor...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  12. Therapeutic potential of biased 5-HT7 receptor ligands in the treatment of depression

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

  13. The influence of muscarinic acetylcholine receptors (M1, M4 and M5) and serotonergic 5-HT1A receptor modulation on cogni...

    Call: PRELUDIUM 16 , Panel: NZ7

    Principal investigator: dr Paulina Agnieszka Cieślik

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  14. Income inequalities, political instability and the deficit bias

    Call: PRELUDIUM 16 , Panel: HS4

    Principal investigator: Łukasz Janikowski

    CASE - Centrum Analiz Społeczno-Ekonomicznych - Fundacja Naukowa

  15. Pharmacological and optogenetic investigation of the mechanism of action of Deep Brain Stimulation of the ventromedial p...

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  16. Evaluation of nervous system cells homeostasis in the experimental in vitro model of cobalamin deficiency as an approach...

    Call: PRELUDIUM 13 , Panel: NZ7

    Principal investigator: Zuzanna Gertruda Rzepka

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

  17. Evaluation of interactions of aripiprazole, the atypical amtipsychotic drug, with the selected antidepressants in the ra...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: dr hab. Zofia Maria Rogóż

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  18. The evaluation of the efficacy of alpha7 nicotinic acetylcholine receptor ligands in rat models of autism

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Anna Nikiforuk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  19. Genetic determinants of psychoactive substances addiction: research on the endophenotype associated with a lack of the r...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: prof. Anna Maria Grzywacz

    Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarsko-Stomatologiczny

  20. Effects of maternal high-fat or high-sugar diet on the impaired NMDA receptor composition and regulation in offspring in...

    Call: SONATA 10 , Panel: NZ7

    Principal investigator: dr hab. Lucyna Pomierny-Chamioło

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

  21. Fiscal illusions in Poland

    Call: SONATA 10 , Panel: HS5

    Principal investigator: dr Przemysław Panfil

    Uniwersytet Gdański, Wydział Prawa i Administracji

  22. Bioanalitycal and pharmacological studies on the compensatory mechanism dependent on MNA/COX-2/PGI2 pathway in NO-defici...

    Call: PRELUDIUM 9 , Panel: NZ7

    Principal investigator: Agnieszka Róża Kij

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)